Join Growin Stock Community!
Beta
Back to CLS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
operating-expenses-chart

CLS Operating Expenses

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

In Q1'26, CLS's operating expenses reached a total of $158.6M USD, with R&D expenses at $41.2M USD and SG&A expenses at $117.4M USD, marking a significant increase from the previous quarter and reflecting heightened investment in administrative and research activities. Over the period from Q2'23 to Q1'26, total operating expenses exhibited volatile growth, rising from $83.4M USD in Q2'23 to a peak of $158.6M USD in Q1'26, driven primarily by sharp escalations in SG&A expenses—such as the jump to $112.5M USD in Q1'25—while R&D expenses showed a more pronounced upward trajectory from $14.3M USD in Q2'23 to $41.2M USD in Q1'26, with notable spikes in Q2'25 and Q3'25; this pattern suggests expanding operational scale amid fluctuating quarterly demands, though periods of decline, like Q4'24's dip to $79.7M USD total, indicate intermittent cost controls.